Screener
Arcus Biosciences RCUS Business Segments — Compensation and personnel costs
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arcus Biosciences in its filing.
Tagged under the XBRL concept us-gaap:LaborAndRelatedExpense.
The source filing: Arcus Biosciences’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:11 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001724521-26-000044
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Adjusted for expense (income): | ||||
| Late-stage development programs (1) | 51 | 74 | 111 | 129 |
| Early-stage development and preclinical programs (2) | 21 | 38 | 39 | 80 |
| Compensation and personnel costs | 58 | 61 | 129 | 128 |
| Depreciation and amortization | 2 | 2 | 5 | 5 |
| Interest income, net | (5) | (8) | (11) | (18) |
| Other segment items (3) | 22 | 26 | 40 | 47 |
| Partnership reimbursements | (17) | (33) | (36) | (71) |
Item 1. Financial Statements
FAQ
- What is Arcus Biosciences's business segments — compensation and personnel costs?
- Arcus Biosciences (RCUS) reported business segments — compensation and personnel costs of $58M in Q2 2026.
- How has Arcus Biosciences's business segments — compensation and personnel costs changed year-over-year?
- Arcus Biosciences's business segments — compensation and personnel costs decreased by 4.9% year-over-year, from $61M to $58M.
- What is the long-term trend for Arcus Biosciences's business segments — compensation and personnel costs?
- Over 3 years (2022 to 2025), Arcus Biosciences's business segments — compensation and personnel costs has grown at a 8.9% compound annual growth rate (CAGR), from $189M to $244M.
- What does business segments — compensation and personnel costs mean?
- Includes all salaries, benefits, stock-based compensation, and related expenses for employees dedicated to the reportable segment. It serves as a primary measure of the human capital investment required to sustain research, development, and operational activities.
Ask your AI about Arcus Biosciences's business segments — compensation and personnel costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude